Digital health company Metronomic has acquired Iron Health, a tech-enabled women’s health provider that serves as an extension of OB/GYN practices. The acquisition, completed on December 30, 2024, aims to integrate Iron Health’s care delivery services with Metronomic’s Materno pregnancy management platform. Iron Health, founded in 2022, has raised $8.5M in funding since its inception and was backed by Redesign Health. The…
Cigna Healthcare has announced a new collaboration with Progyny to make comprehensive fertility and family-building benefits more accessible to employers. The offering, available to most of Cigna’s self-funded employer clients in early fall 2025, will provide coverage throughout the entire fertility journey, from pre-conception planning to postpartum care. “Employers understand that the road to parenthood can be challenging physically, emotionally, and financially,…
Bioceptive and Trimedic have announced a letter of intent to establish a joint venture aimed at bringing the FDA-approved Cervical Suction Retractor (CSR) to market in Canada and the United States. The device offers an alternative to the traditional tenaculum used in gynecological procedures, including IUD insertion. The CSR uses gentle suction instead of the pinching mechanism of the tenaculum, which can…
Ovesse, a vaginal oestrogen cream, has become the first of its kind available over-the-counter in the UK offering new possibilities for millions of postmenopausal women suffering from vaginal atrophy, a condition affecting approximately 50% of women after menopause. Ovesse is a prescription-strength vaginal cream containing estriol, a naturally occurring oestrogen hormone. It’s designed to treat vaginal atrophy by replacing the oestrogen no…
Evernow has announced a partnership with Clearblue to provide users of the Clearblue Menopause Stage Indicator access to specialized menopause healthcare. The collaboration aims to reach up to 35 million women in menopause transition, offering them a path from at-home testing to professional care. Users of Clearblue’s Menopause Stage Indicator, launched in August 2023, will be eligible for a one-month free care…
Celmatix announced a new drug development program targeting endometriosis through a novel Jun-N-terminal kinase (JNK) inhibitor. The therapeutic candidate, developed using Baylor College of Medicine‘s DNA-Encoded Chemistry Technology platform, aims to address pain and inflammation associated with endometriosis. The program targets a significant medical need, as endometriosis affects over 10% of girls and women aged 15-45 worldwide. In the US, the condition…
Healthcare company Ro has announced a collaboration with Eli Lilly and Company to provide patients with streamlined access to Zepbound (tirzepatide) single-dose vials through LillyDirect’s self-pay pharmacy channel. The integration will allow clinically eligible Ro patients to receive the FDA-approved obesity treatment directly through Ro’s platform. Eli Lilly launched LillyDirect earlier this year, marking the first time a major pharmaceutical company has…
Unfabled, a women’s health and wellness platform, has announced a partnership with Boots, the UK’s leading health and beauty retailer, bringing its supplement line to 50 Boots stores. The Unfabled Essentials range includes six products designed to address women’s health concerns including poor sleep, bloating, and low energy. “Our vision has always been to rewrite the consumer experience for women’s health,” said…
